Aptevo Therapeutics announces special shareholder meeting
APVO•Financing-related share issuance proposal
A proposal seeks approval for the potential issuance of common stock tied to Inducement Warrants and Common Warrants from an Aug. 12, 2026 financing.
Special shareholder meeting planned for Sept. 22
Aptevo Therapeutics will hold a virtual special shareholder meeting on Sept. 22, 2026.
Shareholders will vote on an amended and restated certificate of incorporation with technical and administrative updates.
Stock incentive plan update and adjournment authorization
Investors will also decide on the Fifth Amended and Restated 2018 Stock Incentive Plan, including 180,000 additional shares for equity awards.
An adjournment authorization is on the ballot to allow additional solicitation if votes are insufficient on key items.
